Cigna (CI) Gains Analyst Attention as Goldman Sachs and Wells Fargo Lift Outlooks
On October 14, Goldman Sachs analyst Scott Fidel initiated coverage of The Cigna Group (NYSE:CI) with a Buy rating and a price target of $370.
Cigna Group (CI)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | GQG Partners Rajiv Jain | 5,769,691 | $1,907,356,730 | +19% | 2.71% |
| 2. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 2,508,740 | $829,339,269 | +25% | 0.59% |
| 3. | Citadel Investment Group Ken Griffin | 1,236,239 | $408,675,888 | +1462% | 0.07% |
| 4. | AQR Capital Management Cliff Asness | 1,136,394 | $372,612,124 | -2% | 0.31% |
| 5. | 1,059,500 | $350,249,510 | -6% | 21.48% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $211.59 | 500 | $105,794.00 | 26,202 | 2021-08-11 | Filing | |
| $209.89 | 500 | $104,946.50 | 25,702 | 2021-08-10 | Filing | |
| $168.77 | 1,000 | $168,768.00 | 26,555 | 2020-09-11 | Filing | |
| $187.37 | 5,460 | $1,023,017.81 | 31,642 | 2020-06-15 | Filing | |
| $195.04 | 4,100 | $799,659.90 | 25,683 | 2019-12-03 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $300.00 | 5,368 | $1,610,400.00 | 51,182 | 2025-10-03 | Filing | |
| $300.00 | 28,526 | $8,557,800.00 | 25,648 | 2025-08-15 | Filing | |
| $310.35 | 2,376 | $737,391.60 | 5,471 | 2025-03-14 | Filing | |
| $320.00 | 9,944 | $3,182,080.00 | 13,406 | 2025-03-07 | Filing | |
| $308.12 | 26,527 | $8,173,499.24 | 127,767 | 2025-03-03 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 615,187 | $177,327,655 | 0.18% | |
| 2. | 314,330 | $90,605,623 | 0.12% | |
| 3. | 121,764 | $35,098,578 | 2.93% | |
| 4. | 105,474 | $30,403,018 | 5.58% | |
| 5. | 89,098 | $25,682,498 | 0.03% |
News See All
11 Defensive Healthcare Dividend Stocks To Buy Now
US healthcare stocks have been under mounting pressure this year, largely due to policies introduced by the Trump administration.
UBS Views Cigna (CI) as Top Choice in Healthcare Managed Care Sector
The Cigna Group (NYSE:CI) ranks among the stocks with low beta that can beat market volatility.
13 Stocks With Low Beta That Can Beat Market Volatility
In August, consumer spending and income both exceeded expectations. With the relatively low rate of inflation, companies and consumers are still placing orders for costly products.
The Cigna Group (CI): A Bull Case Theory
We came across a bullish thesis on The Cigna Group on Investing With Purpose’s Substack. In this article, we will summarize the bulls’ thesis on CI.
Cigna Group Expands Coverage for Home Phototherapy, Benefits Millions with Chronic Skin Conditions
The Cigna Group (NYSE:CI) is one of the best inexpensive stocks to buy according to hedge funds.
10 Best Inexpensive Stocks to Buy According to Hedge Funds
On August 30, Ryan Detrick, Carson Group chief market strategist, joined 'Closing Bell' on CNBC and noted that we're in a bull market, but seasonal weakness wouldn't be shocking.
Jim Cramer Discussed These 11 Stocks
Cramer pointed out that previously, investors who have remained patient and stuck with high-quality stocks, not just index funds like the S&P 500, have seen substantial returns over time.
Strong Fundamentals Make Cigna (CI) a Compelling Value Play, Says Guggenheim
The Cigna Group (NYSE:CI) is one of the deep value stocks to buy according to analysts. Cigna’s shares are up about 4% year-to-date, lagging the broader market.
11 Deep Value Stocks to Buy According to Analysts
In today’s market, where investor attention has focused on a handful of mega-cap technology names, the appeal of value investing has resurfaced.